ZonMw — Netherlands Organisation for Health Research and Development logo
NWA Reducing Drug Harm: Toward Effective Social Interventions (NWA Drugsschade terugdringen: naar effectieve maatschappelijke interventies)

NWA Reducing Drug Harm — Pre-applications Phase 1 (Drugsschade terugdringen)

Funds Dutch research and societal consortia investigating drug-related harm and testing interventions to improve public policy outcomes.

NWA Drugsschade terugdringen — Pre-applications Phase 1 is a competitive pre-proposal round administered by ZonMw on behalf of the Dutch National Research Agenda (NWA). The programme targets the full spectrum of drug-related harm: health impacts, economic consequences, safety implications, and damage to the living environment arising from drug use, production, and trafficking in the Netherlands. T…

Drug-related harm reduction — health, economic, safety, and living-environment impacts of drug use, production, and trafficking, including mechanisms and effective societal interventions.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.Multiple per year
Next deadlineiThe next date applications are due. Rolling means you can apply any time.-
Decision timeiTypical time from the deadline to the funder's decision.-
Project durationiHow long the funded work is expected to run.12–60 months
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.€4.3M

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see the timeline

Guides for this application

All guides →
ZonMw — Netherlands Organisation for Health Research and Development logo
Open

Infectieziektebestrijding — Verspreiding en implementatie impuls

🇳🇱ZonMw · Netherlands

Funds Dutch translational studies to spread infectious disease control knowledge and turn evidence into routine practice.

Biotech
€50KDec'28
ZonMw — Netherlands Organisation for Health Research and Development logo
Open

Alcohol Prevention: Strengthening Practice (Alcoholpreventie: versterken van de praktijk)

🇳🇱ZonMw · Netherlands

Funds Dutch organizations to implement evidence-based alcohol prevention knowledge in practical public health programs and community settings.

Biotech
€50K
ZonMw — Netherlands Organisation for Health Research and Development logo
Between cycles

PSIDER — Netwerksubsidies

🇳🇱ZonMw · Netherlands

Funds Dutch knowledge networks that connect institutions internationally and strengthen research communities through shared learning activities.

Biotech
€50K
ZonMw — Netherlands Organisation for Health Research and Development logo
Closed

Large Trials Round 7 — Good Use of Medicines (Grote Trials Ronde 7 — Goed Gebruik Geneesmiddelen)

🇳🇱ZonMw · Netherlands

Funds large Dutch clinical trials producing evidence for safer, more effective, and cost efficient medicine use.

BiotechMedtech
ZonMw — Netherlands Organisation for Health Research and Development logo
Closed

Pilots Infectious Disease Control — From Small Steps to Great Insights (Pilots Infectieziektebestrijding — van kleine stappen naar grote inzichten)

🇳🇱ZonMw · Netherlands

Funds Dutch pilot studies in infectious disease prevention that generate practical insights for wider implementation.

Biotech
€50K
ZonMw — Netherlands Organisation for Health Research and Development logo
Closed

Research Impulse for Infectious Disease Control (Onderzoeksimpuls Infectieziektebestrijding)

🇳🇱ZonMw · Netherlands

Funds Dutch teams that strengthen ongoing infectious disease programmes with applied research and practical health system integration.

Biotech
€50K
European Commission logo
Scheduled

AI Predictive Biomarkers for Chronic Diseases

🇪🇺European Commission · European Union

Funds trustworthy AI biomarker methods that predict chronic-disease progression and treatment response for personalised care.

MedtechBiotech+1
€6M – €8MApr'27
European Commission logo
Scheduled

Cancer Mission: First-in-Human Trials for Rare Cancers

🇪🇺European Commission · European Union

Funds €7–9M projects taking biomarker-guided rare-cancer treatments into first-in-human, multicentre phase 1 trials.

BiotechMedtech+1
€7M – €9MSep'27
European Commission logo
Scheduled

Cancer Mission: Functional Genomics for New Treatments

🇪🇺European Commission · European Union

Funds €7–8M projects that use functional genomics and patient data to uncover precise new targets for difficult-to-treat cancers.

BiotechMedtech+2
€7M – €8MSep'27
European Commission logo
Scheduled

Towards Artificial General Intelligence (AGI) for healthcare

🇪🇺European Commission · European Union

Funds a European community and roadmap for trustworthy frontier AI models in healthcare.

AIBiotech+1
€2.9MSep'27
European Innovation Council logo
Open

EIC Pathfinder Challenges

🇪🇺EIC · European Union

Funds European consortia developing breakthrough solutions across AI, climate, energy, materials, medical, and quantum fields.

AIBiotech+5
€4MOct'26
European Commission logo
Open

ERC Starting Grant

🇪🇺European Commission · European Union

Funds early-career researchers building an independent research team and pursuing frontier research through an ERC Starting Grant hosted at a public or private research organisation.

BiotechAI+5
€1.5MOct'26